Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment

NCT00567047 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Type-2 Diabetes

Interventions

DRUG: vildagliptin

Sponsor

Novartis